Examination report on the City of Riverdale, Iowa for the period July 1, 2012 through June 30, 2013

Examination report on the City of Riverdale, Iowa for the period July 1, 2012 through June 30, 2013

Examination report on the City of Bedford, Iowa for the period July 1, 2012 through June 30, 2013

Examination report on the City of Bedford, Iowa for the period July 1, 2012 through June 30, 2013

Examination report on the City of State Center, Iowa for the period July 1, 2012 through June 30, 2013

Examination report on the City of State Center, Iowa for the period July 1, 2012 through June 30, 2013

Examination report on the City of Mechanicsville, Iowa for the period July 1, 2012 through June 30, 2013

Examination report on the City of Mechanicsville, Iowa for the period July 1, 2012 through June 30, 2013

Examination report on the City of Roland, Iowa for the period July 1, 2012 through June 30, 2013

Examination report on the City of Roland, Iowa for the period July 1, 2012 through June 30, 2013

Examination report on the City of Newhall, Iowa for the period July 1, 2012 through June 30, 2013

Examination report on the City of Newhall, Iowa for the period July 1, 2012 through June 30, 2013

Examination report on the City of Gilmore City, Iowa for the period July 1, 2012 through June 30, 2013

Examination report on the City of Gilmore City, Iowa for the period July 1, 2012 through June 30, 2013

Report on a review of the operations of certain departments of the University of Iowa Hospitals and Clinics for the period July 1, 2010 through December 31, 2012

Report on a review of the operations of certain departments of the University of Iowa Hospitals and Clinics for the period July 1, 2010 through December 31, 2012

Report on a special investigation of the University of Iowa Hospitals and Clinics, Health Care Information Systems Department, for the period January 1, 2005 through July 5, 2013

Report on a special investigation of the University of Iowa Hospitals and Clinics, Health Care Information Systems Department, for the period January 1, 2005 through July 5, 2013

Examination report on the City of Swea City, Iowa for the period July 1, 2012 through June 30, 2013

Examination report on the City of Swea City, Iowa for the period July 1, 2012 through June 30, 2013

Report on a special investigation of the City of Kinross for the period January 15, 2008 through October 31, 2013

Report on a special investigation of the City of Kinross for the period January 15, 2008 through October 31, 2013

Peri-operative management of antiplatelet therapy in patients with coronary artery disease. Joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC).

An increasing number of patients suffering from cardiovascular disease, especially coronary artery disease (CAD), are treated with aspirin and/or clopidogrel for the prevention of major adverse events. Unfortunately, there are no specific, widely accepted recommendations for the perioperative management of patients receiving antiplatelet therapy. Therefore, members of the Perioperative Haemostasis Group of the Society on Thrombosis and Haemostasis Research (GTH), the Perioperative Coagulation Group of the Austrian Society for Anesthesiology, Reanimation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society of Cardiology (ESC) have created this consensus position paper to provide clear recommendations on the perioperative use of anti-platelet agents (specifically with semi-urgent and urgent surgery), strongly supporting a multidisciplinary approach to optimize the treatment of individual patients with coronary artery disease who need major cardiac and non-cardiac surgery. With planned surgery, drug eluting stents (DES) should not be used unless surgery can be delayed for ≥12 months after DES implantation. If surgery cannot be delayed, surgical revascularisation, bare-metal stents or pure balloon angioplasty should be considered. During ongoing antiplatelet therapy, elective surgery should be delayed for the recommended duration of treatment. In patients with semi-urgent surgery, the decision to prematurely stop one or both antiplatelet agents (at least 5 days pre-operatively) has to be taken after multidisciplinary consultation, evaluating the individual thrombotic and bleeding risk. Urgently needed surgery has to take place under full antiplatelet therapy despite the increased bleeding risk. A multidisciplinary approach for optimal antithrombotic and haemostatic patient management is thus mandatory.

Examination report on the City of Lansing, Iowa for the period July 1, 2012 through June 30, 2013

Examination report on the City of Lansing, Iowa for the period July 1, 2012 through June 30, 2013

Examination report on the City of Atkins, Iowa for the period July 1, 2012 through June 30, 2013

Examination report on the City of Atkins, Iowa for the period July 1, 2012 through June 30, 2013

Agreed-upon procedures report on the Iowa Sheep and Wool Promotion Board for the period July 1, 2011 through June 30, 2013

Agreed-upon procedures report on the Iowa Sheep and Wool Promotion Board for the period July 1, 2011 through June 30, 2013